Targeting specific trypsin enzymes to improve cancer treatment
Exploiting new approaches for selective inhibition of trypsins
This study is working on creating new medicines that can specifically block certain harmful enzymes linked to cancer and pancreatitis, aiming to improve treatment options and outcomes for patients dealing with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Jacksonville NIH-funded |
| Lab location | 1 site (Jacksonville, United States) |
| Project ID | NIH-10983328 on NIH RePORTER |
What this research studies
This research focuses on developing new inhibitors that selectively target different isoforms of the trypsin enzymes, which are involved in cancer and pancreatitis. By using advanced techniques like virtual screening and structural analysis, the team aims to create more effective treatments that can specifically inhibit harmful trypsins without affecting beneficial ones. This approach could lead to better therapeutic strategies in preclinical models, potentially improving patient outcomes in diseases where these enzymes play a critical role.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with cancer or pancreatitis who may benefit from targeted enzyme inhibition.
Not a fit: Patients with conditions unrelated to trypsin enzymes or those who do not have cancer or pancreatitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted treatments for patients with cancer and pancreatitis.
How similar studies have performed: Previous research has shown promise in developing selective inhibitors for similar proteases, indicating potential success for this novel approach.
Where this research is happening
Jacksonville, United States
- Mayo Clinic Jacksonville — Jacksonville, United States (Active)
Researchers
- Principal investigator: Radisky, Evette S — Mayo Clinic Jacksonville
- Study coordinator: Radisky, Evette S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.